Bayview Pharmacy is pleased to present a specialized topical cream formulation of Montelukast 1%/Ketotifen 0.05%. This unique combination of medications has demonstrated efficacy in managing a range of allergic and inflammatory conditions, such as asthma, allergic rhinitis, atopic dermatitis, urticaria, and chronic idiopathic urticaria.

Montelukast is a leukotriene receptor antagonist that functions by inhibiting the action of leukotrienes, chemicals that trigger inflammation in the airways. This mechanism helps alleviate asthma symptoms, including wheezing, coughing, and shortness of breath.

Ketotifen, on the other hand, is an antihistamine that operates by blocking the action of histamine, a chemical that the body releases during an allergic reaction. This action helps mitigate the symptoms of allergic rhinitis, such as sneezing, itching, and a runny nose. Additionally, it aids in reducing the inflammation and itching associated with atopic dermatitis, urticaria, and chronic idiopathic urticaria.

The Montelukast 1%/Ketotifen 0.05% Topical Cream is dispensed in a pump mechanism, a semisolid preparation designed for convenient and controlled application on the skin. This allows for localized treatment or absorption of the active ingredients, providing targeted relief from symptoms.

This combination of Montelukast and Ketotifen in a topical cream form offers an effective treatment strategy for various allergic and inflammatory conditions. If you have any queries or require further information about this formulation, please do not hesitate to contact us at Bayview Pharmacy.

Montelukast 1%/Ketotifen 0.05% Topical Cream is a compounded formulation designed for localized treatment of various conditions such as asthma, allergic rhinitis, atopic dermatitis, urticaria, and chronic idiopathic urticaria. This semisolid preparation is dispensed in a pump mechanism for convenient and controlled application on the skin.

The active ingredients in this formulation are Montelukast and Ketotifen. Montelukast is a leukotriene receptor antagonist that blocks the action of leukotrienes, inflammatory mediators that can cause bronchoconstriction, mucus secretion, and airway inflammation. Ketotifen, on the other hand, is a mast cell stabilizer that inhibits the release of histamine and other inflammatory mediators from mast cells. Together, these two medications work synergistically to reduce inflammation and improve symptoms associated with these conditions.

For the treatment of asthma, allergic rhinitis, atopic dermatitis, urticaria, and chronic idiopathic urticaria, Montelukast 1%/Ketotifen 0.05% Topical Cream should be applied twice daily to the affected area. However, it is crucial to understand that this formulation should not be used as a substitute for inhaled corticosteroids, antihistamines, topical corticosteroids, or other medications prescribed by your healthcare provider for these conditions.

Patients with known hypersensitivity to either Montelukast or Ketotifen should not use this formulation. If you have any questions or concerns about the use of Montelukast 1%/Ketotifen 0.05% Topical Cream, it is recommended to consult with your healthcare provider for further guidance.

Montelukast 1%/Ketotifen 0.05% Topical Cream is a specially compounded medication designed to treat a range of conditions such as asthma, allergic rhinitis, atopic dermatitis, urticaria, and chronic idiopathic urticaria. This unique formulation combines the anti-inflammatory properties of Montelukast, a leukotriene receptor antagonist, with the antihistamine effects of Ketotifen. By blocking the actions of leukotrienes and histamine, substances in the body that cause inflammation and allergic reactions respectively, this cream provides effective relief from the symptoms associated with these conditions.

The cream is a semisolid preparation dispensed in a pump mechanism, which allows for convenient and controlled application on the skin. It is designed for localized treatment, enabling the active ingredients to be absorbed directly into the affected area. The cream should be applied twice daily, or as directed by your healthcare provider, and care should be taken to avoid contact with the eyes, nose, and mouth. If accidental contact occurs, rinse the area thoroughly with water.

While Montelukast 1%/Ketotifen 0.05% Topical Cream is generally well tolerated, some individuals may experience side effects such as skin irritation, burning, or itching. If you experience any of these or other side effects, it is important to contact your healthcare provider for advice.

If you have any questions or concerns about using Montelukast 1%/Ketotifen 0.05% Topical Cream, please do not hesitate to reach out. Our team of compounding pharmacists at Bayview Pharmacy is always here to provide the information and support you need.

Montelukast 1%/Ketotifen 0.05% Topical Cream is a compounded formulation that has demonstrated efficacy in the treatment of a wide range of conditions. This includes allergic conjunctivitis, a condition characterized by inflammation of the conjunctiva due to allergies, and eosinophilic esophagitis, a chronic immune system disease. It has also been found effective in managing mastocytosis, a disorder characterized by an excessive number of mast cells in the body.

Moreover, this topical cream has been utilized to alleviate the severity of symptoms associated with seasonal allergies. These symptoms may include sneezing, itching, and nasal congestion. The cream's active ingredients work to counteract these symptoms, providing relief and comfort to the user.

Additionally, Montelukast 1%/Ketotifen 0.05% Topical Cream has been used to mitigate the severity of symptoms associated with contact dermatitis. This skin condition, which can cause redness, itching, and swelling, can be effectively managed with the regular application of this cream.

Furthermore, this formulation has been used to reduce the severity of symptoms associated with atopic dermatitis. This includes symptoms such as redness, itching, and scaling. The cream's active ingredients work to soothe the skin and reduce inflammation, providing relief from these symptoms.

Finally, this formulation has been used to reduce the severity of symptoms associated with urticaria, also known as hives. This includes symptoms such as redness, itching, and the appearance of hives. The cream's active ingredients work to soothe the skin and reduce inflammation, providing relief from these symptoms.

If you have any questions about the use of Montelukast 1%/Ketotifen 0.05% Topical Cream for any of these conditions, please do not hesitate to reach out for further information.